Updated Phase 3 Data from 2025: The Numbers Got Even Better In December 2025, Eli Lilly released topline results from the TRIUMPH-4 Phase 3 trial, and the numbers exceeded even the most optimistic projections from Wall Street analysts
Bastianetto S, Quirion R (2004) Natural antioxidants and neurodegenerative diseases
Begin by reviewing your medical history and ensuring your healthcare provider is fully aware of all medications, supplements, and health conditions you have
Supergut is already very well-positioned for this Ozempic era, and were seeing a significant surge in demand from consumers looking for a natural approach to curb cravings, support health weight management, and nourish your gut for improved digestive health. But the surge in popularity also brings about one of the brands biggest obstacles: scaling up operations and supply chains to keep up with the demand
Cloning, identification and functional characterization of a pi-class glutathione-S-transferase from the freshwater mussel Cristaria plicata